Anzeige
Mehr »
Login
Montag, 27.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40RA3 | ISIN: US56270V2051 | Ticker-Symbol:
NASDAQ
24.01.25
17:15 Uhr
2,930 US-Dollar
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
MANGOCEUTICALS INC Chart 1 Jahr
5-Tage-Chart
MANGOCEUTICALS INC 5-Tage-Chart

Aktuelle News zur MANGOCEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15.01.MANGOCEUTICALS, INC. - 8-K, Current Report-
08.01.MANGOCEUTICALS, INC. - 8-K, Current Report-
26.12.24MANGOCEUTICALS, INC. - 8-K, Current Report-
19.12.24Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent2
MANGOCEUTICALS Aktie jetzt für 0€ handeln
19.12.24MANGOCEUTICALS, INC. - 8-K, Current Report-
06.12.24MANGOCEUTICALS, INC. - 8-K, Current Report-
04.12.24Mangoceuticals untersucht ungewöhnliche Aktienaktivitäten nach Aktiensplit2
04.12.24Mangoceuticals probes unusual stock activity post-split3
04.12.24Mangoceuticals, Inc. Initiates Investigation into Potential Stock Manipulation Scheme Following Recent Reverse Stock Split66DALLAS, TX, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, and selling men's health and wellness products...
► Artikel lesen
12.11.24MANGOCEUTICALS, INC. - 8-K, Current Report-
01.11.24MGRX stock touches 52-week low at $2.1 amid market challenges1
31.10.24MANGOCEUTICALS, INC. - 8-K, Current Report1
25.10.24Mangoceuticals issues shares, raises $78,787 in capital1
22.10.24MangoRx hits back at Eli Lilly's weight loss drug copycat claims6
22.10.24Mangoceuticals Opts For Strategic Alternatives1
22.10.24Mangoceuticals explores strategic alternatives to boost shareholder value2
22.10.24Mangoceuticals To Defend Against Eli Lilly's Lawsuit Over Alleged Copying Of Weight-Loss Drugs426INDIANAPOLIS (dpa-AFX) - Mangoceuticals Inc. (MGRX) announced that Eli Lilly has made public allegations and filed a lawsuit against the company, claiming that MangoRx improperly copied its...
► Artikel lesen
22.10.24Mangoceuticals refutes claims made by Lilly in weight-loss drug lawsuit6
21.10.24MangoRx faces lawsuit from Eli Lilly over medication5
21.10.24Mangoceuticals, Inc.: MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly243Dallas, Texas, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, and selling men's health and wellness...
► Artikel lesen
Seite:  Weiter >>
52 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1